~~<i id='4DE123FEFD'><strike id='4DE123FEFD'><tt id='4DE123FEFD'><pre id='4DE123FEFD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：fashion 2025-09-27 23:53:01 - browse：866

Elite athletes really are different from you and me. Or, at least their gut microbes are.

Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particular microbe compared to 10 non-athletes. Levels of the microbe in question, Veillonella, spiked after an intense workout and bloomed even more after the marathon.

That was a lightbulb moment for the scientists because the bacterium is known for breaking down and eating lactate, a metabolite even ordinary runners equate with fatigue.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： An outdated Medicare rule harms dementia patients with anxiety

knowledge

focus

explore

focus

Wikipedia

MollyFerguson/STATCHICAGO—SomethingisoffaboutthewayNovartisistalkingaboutpelabresib,itsnewlyacquired

WSS

AdventHealth escalates lawsuit against insurance vendor Multiplan

Videos point to link between seizures and unexplained toddler deaths

Chronically ill young patients struggle to find fertility info

The most pressing bird flu mysteries scientists want answered

Medicare Advantage's lean provider networks lead CMS complaints

Structure Therapeutics oral GLP

explore

hotspot

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Goldman Sachs launches $650M fund for life science investments

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Goldman Sachs launches $650M fund for life science investments

Cancer drug shortages should be causing more outrage

STAT wants to know your pick for a great summer read or listen

Apple is now the first public company to be valued at $3 trillion

UCB departs biotech trade group BIO

ChatGPT in medicine: STAT answers readers' burning questions

Goldman Sachs launches $650M fund for life science investments

focus

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Take antibiotics after sex, CDC recommends for certain risk groups

Stopping antidepressants leads to symptoms for 1 in 6 patients

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Congress needs to close a vaccine

Sutter Health’s antitrust win overturned by appeals court

focus

explore

focus

Wikipedia